ENGVALL et al. V. DAVID et al. - Page 22




                   specification indicates Engvall never conveyed any concern with the magnitude of the affinity of the                                                
                   monoclonals and antigens used.                                                                                                                      
                             On the other hand, Engvall did have concern for the specificity of the monoclonals.  Indeed,                                              
                   the reason stated in the specification for employing monoclonals in her assays was the high specificity                                             
                   of the these antibodies.  Engvall Application 06/539,754, specification, p. 4, lines 13 to 25.                                                      
                             Engvall's specification begins by identifying that the technological field of the invention is                                            
                   sandwich assays involving the use of two antibodies which are active against the same antigen:                                                      
                                                 [T]he present invention relates to a method for the determination of                                                  
                                                 an antigen (I) in solution, in which determination said antigen (I) is                                                
                                                 reacted with an antibody (II), which is directed against the antigen (I)                                              
                                                 and with an antibody (III), which is directed against the antigen (I)                                                 
                                                 and is labeled with an analytically indicatable atom or group and is                                                  
                                                 soluble in the liquid in the presence of which the determination is                                                   
                                                 carried out, to the formation of a conjugate comprising said antigen                                                  
                                                 (I) and said antibodies (II) and (III), which conjugate is insoluble or                                               
                                                 is made insoluble, whereafter the analytically indicatable atom or                                                    
                                                 group is determined in the insoluble or insolubilized conjugate and/or                                                
                                                 in the solution.                                                                                                      
                   Engvall Application 06/539,754, specification, p. 1, lines 3-14.  The specification goes on to indicate                                             
                   that assay methods using biospecific affinity reactions are well known.  At page 2, lines 1-11, of her                                              
                   specification Engvall states:                                                                                                                       
                                                 A  great  number  of  assay  methods  involving  biospecific  affinity                                                
                                                 reactions [are] known in which methods a first immunochemical                                                         
                                                 reactant is reacted with a second immunochemical reactant exhibiting                                                  
                                                 biospecific affin[ity] to said first reactant and then a third                                                        
                                                 immunochemical reactant, which exhibits biospecific affinity to the                                                   
                                                 first or  the  .  .  .  second  reactant  (i.e.,  is  an  immunochemical                                              
                                                 counterpart to the first or the second reactant) is reacted with its                                                  
                                                 counterpart to the formation of a conjugate comprising said first,                                                    
                                                 second and third reactants, one of said reactants being labeled with an                                               
                                                 analytically indicatable atom or group of atoms.                                                                      
                             Engvall further notes that in order to determine the presence of the second reactant, the                                                 
                   labeled conjugate must be separated from the labeled but unreacted component.  She indicates that                                                   
                   this is commonly done by using, as one of the reactants, a component bound to an insoluble polymer.                                                 
                   The labeled conjugate is removed by simply removing the polymer with the bound conjugate from                                                       


                                                                                 19                                                                                    





Page:  Previous  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  Next 

Last modified: November 3, 2007